Skip to main content

Table 2 Whole exome sequencing of four invasive lobular cancer (ILC) samples and four lobular carcinoma in situ (LCIS) samples (one paired): mutations occurring in two or more samples

From: PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

Gene Chrom Number of ILC
samples with
mutation
Number of LCIS
samples with
mutation
Total
HSPG2 1 1 1 2
ROR1 1 1 1 2
SMG7 1 1 1 2
TSSC1 2 2 0 2
PIK3CA 3 3 3 6
DOCK2 5 1 1 2
HAND1 5 2 0 2
UTP23 8 2 0 2
CACNB2 10 1 1 2
COX15 10 1 1 2
OR56B1 11 1 1 2
DDX11 12 1 1 2
PROSER1 13 1 1 2
TPTE2 13 1 1 2
PAK6 15 2 0 2
CDH1 16 3 3 6
PTRF 17 1 1 2
ATP11C X 1 1 2
ATRX X 1 1 2